Skip to content

Comparison of the effect of Ceratonia siliqua fruit oral capsule and vitamin E in male infertility

Comparison of the effect of Ceratonia siliqua fruit oral capsule and vitamin E on semen parameters in idiopathic infertile men

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016041027311N1
Enrollment
70
Registered
2017-02-14
Start date
2017-02-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

male infertility. male infertility

Interventions

Intervention 1: Intervention Group: 500 mg carob fruit Oral Capsules three times a day for 90 days. Intervention 2: Control group: oral 500 mg vitamin E capsules containing 100 mg of vitamin E and 400
Treatment - Drugs
Intervention Group: 500 mg carob fruit Oral Capsules three times a day for 90 days
Control group: oral 500 mg vitamin E capsules containing 100 mg of vitamin E and 400 mg starch

Sponsors

Research Deputy of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 20-45 years; married infertile man for at least one year with idiopathic abnormal spermogram about number; motility and morphology according to the World Health Organization (sperm count Less than 20 million per milliliter,type A mobility less than 25 percent and type B mobility less than 50% and normal morphology less than 30% ); non-smoking and non-alcoholism and drug users; desire to participate in the study; the ability to read and write Exclusion criteria: Being azospermic; infection and anatomical abnormalities of the genital tract such as duct blockage; to develop a varicocele ; surgery or need to do pelvic region surgery; diseases as cancer, liver and gallbladder, diabetes, thyroid, kidney failure, uncontrolled hypertension, cerebral hemorrhage, retinal hemorrhage, unilateral testicular atrophy; history of chemotherapy drugs, corticosteroids, anticoagulation, testosterone, antiandrogen; taking any other chemical, or certain herbal infertility drugs during the project and in the last quarter; recent consumption of vitamin E

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sperm count. Timepoint: Before and three months after intervention. Method of measurement: Semen analysis.;Sperm motility. Timepoint: Before and three months after intervention. Method of measurement: Semen analysis.;Sperm morphology. Timepoint: Before and three months after intervention. Method of measurement: Semen analysis.

Secondary

MeasureTime frame
Sexual function. Timepoint: Before and three months after intervention. Method of measurement: Sexual Function Questionnaire.;Side events. Timepoint: three months after intervention. Method of measurement: check list complete.;Satisfaction with treatment received. Timepoint: three months after intervention. Method of measurement: check list complete.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSima Sanagoo

Tabriz University of Medical Sciences

www.midwife.life20@gmail.com+98 914 102 4284

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026